About Associate Professor Joshua Burns
The ultimate goal of our research activities is to reduce the burden of neurological and musculoskeletal disorders, both on patient and society, and promote excellence and innovation in research and clinical practice so that the latest in therapy is available throughout Australia, and internationally.
Associate Professor Burns combines research and clinical training in Podiatry, Physiotherapy and Neurology. This mix provides a unique base on which he has become a productive clinical researcher. He is currently a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellow investigating treatments for children and adults with inherited neuropathy and other neuromuscular disorders.
During 2000 Associate Professor Burns received a 1st Class Honours Degree with the University Medal for Podiatry. His Honours research established risk factors for lower limb injury in amateur to elite triathletes. During 2006 he received a PhD in Physiotherapy. His thesis established assessment and treatment methods for foot problems of adults with nerve and muscle disorders. During 2009 he completed a National Health and Medical Research Council of Australia (NHMRC) Postdoctoral Fellowship in the field of Neurology evaluating therapies for children with neuromuscular disorders such as Charcot-Marie-Tooth disease. During this time he received the Young Tall Poppy Science Award for excellence in Podiatry and Paediatric Neurology in 2008 and was awarded the National Fulbright Postdoctoral Scholarship for 2009 to work in the USA.
- Burns J. Ouvrier R. Estilow T. Shy R. Laurá M. Pallant J. Lek M. Muntoni F. Reilly M. Pareyson D. Acsadi G. Shy M. Finkel R. Validation of the CMT Pediatric Scale as an outcome measure of disability. Annals of Neurology 71(5), 642-652, 2012.
- Burns J. Begg L. Optimizing the offloading properties of the total contact cast for plantar foot ulceration. Diabetic Medicine 28 (2), 179-185, 2011.
- Burns J, Ramchandren S, Ryan MM, Shy M, Ouvrier RA. Determinants of reduced health-related quality of life in pediatric inherited neuropathies. Neurology 75(8):726-31, 2010.
- Burns J. Ouvrier RA. Yiu EM. Joseph PD. Kornberg AJ. Fahey MC. Ryan MM. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurology. 8 (6) 537-544, 2009.
- Burns J. Ryan MM. Ouvrier RA. Evolution of foot and ankle manifestations in children with CMT1A. Muscle & Nerve 39(2) 158-66, 2009.
- Burns J. Bray P. Cross L. North KN. Ryan MM. Ouvrier RA. Hand involvement in children with Charcot-Marie-Tooth disease type 1A. Neuromuscular Disorders 18(12):970-973, 2008.
- Burns J. Landorf KB. Ryan MM. Crosbie J. Ouvrier RA. Interventions for the prevention and treatment of pes cavus. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006154. DOI: 10.1002/14651858.CD006154.pub2.
- Burns J. Crosbie J. Ouvrier R. Hunt A. Effective orthotic therapy for the painful cavus foot: a randomized controlled trial. Journal of the American Podiatric Medical Association. 96(3):205-11, 2006.
- Burns J. Crosbie J. Hunt A. Ouvrier R. Novel Award: The effect of pes cavus on foot pain and plantar pressure. Clinical Biomechanics. 20(9):877-82, 2005.
- Burns J. Keenan AM. Redmond AC. Factors associated with triathlon-related overuse injuries. Journal of Orthopaedic & Sports Physical Therapy. 33(4):177-84, 2003